Barclays Maintains an 'Overweight' on ArvinMeritor (ARM); Strong Earnings Outlook Intact Despite Lower Incremental Margins
Tweet Send to a Friend
Barclays maintains an 'Overweight' on ArvinMeritor (NYSE: ARM), PT $25.
Barclays analyst says, "Selloff unwarranted given net positive quarter and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Selloff unwarranted given net positive quarter and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
